Higher RUNX1 expression levels are associated with worse overall and leukaemia‐free survival in myelodysplastic syndrome patients

RUNX1 mutations are frequently detected in various myeloid neoplasms and implicate unfavourable clinical outcomes in patients with myelodysplastic syndrome (MDS) and acute myeloid leukaemia (AML). On the other hand, high expression of RUNX1 is also correlated with poor prognosis in AML patients. How...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yu‐Hung, Yao, Chi‐Yuan, Lin, Chien‐Chin, Chen, Chi‐Ling, Hsu, Chia‐Lang, Tsai, Cheng‐Hong, Hou, Hsin‐An, Chou, Wen‐Chien, Tien, Hwei‐Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Haematologic Malignancy ‐ Myeloid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713038/
https://www.ncbi.nlm.nih.gov/pubmed/36467848
http://dx.doi.org/10.1002/jha2.547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713038/
https://www.ncbi.nlm.nih.gov/pubmed/36467848
http://dx.doi.org/10.1002/jha2.547

Ejemplares similares